Promaxo Receives 510(k) Clearance from the FDA for its Innovational MRI Platform
/
DateMar 08 2021
The United States Food and Drug Administration (FDA) has granted Promaxo, Inc. (Promaxo) a 510(k) clearance for its revolutionary office-based MRI system. The 510(k) clearance enables practices and hospitals to accurately and seamlessly guide prostate interventions under the Promaxo scanner. Read More →